Malnique, F. et al. 2025. COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT. Seven Editora. (Nov. 2025), 316–330.